Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ali Hajjar"'
Autor:
Yifan Lu, Ali Hajjar, Vincent L. Cryns, Amy Trentham‐Dietz, Ronald E. Gangnon, Brandy M. Heckman‐Stoddard, Oguzhan Alagoz
Publikováno v:
Cancer Medicine, Vol 12, Iss 10, Pp 11703-11718 (2023)
Abstract Background Diabetes mellitus has been associated with increased breast cancer (BC) risk; however, the magnitude of this effect is uncertain. This study focused on BC risk for women with type 2 diabetes mellitus (T2DM). Methods Two separate m
Externí odkaz:
https://doaj.org/article/05ec6330400c4aa4ae9fb75302950c00
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0217778 (2019)
ObjectivesAdjuvant paclitaxel and trastuzumab has been shown to be an effective regimen with low risk of cancer recurrence and treatment-related toxicities in early-stage node-negative, HER2-positive breast cancer. We investigated the cost-effectiven
Externí odkaz:
https://doaj.org/article/4dba9a197f66495298f1bfa4d13b025c
Autor:
Ali Hajjar, Oguzhan Alagoz
Publikováno v:
Management Science. 69:260-282
Clinical practice guidelines do not sufficiently address the needs of patients with chronic conditions as these guidelines focus on single disease management and ignore unique patient-specific conditions. As a result, a nonpersonalized approach to th
Autor:
Peter P. Mueller, Qiushi Chen, Turgay Ayer, Gizem S. Nemutlu, Ali Hajjar, Emily D. Bethea, Mary Linton B. Peters, Brian P. Lee, Naveed Z. Janjua, Fasiha Kanwal, Jagpreet Chhatwal
Publikováno v:
J Hepatol
BACKGROUND & AIMS: Successful treatment of chronic hepatitis C with oral direct-acting antivirals (DAAs) leads to virological cure, however, the subsequent risk of hepatocellular carcinoma (HCC) persists. Our objective was to evaluate the cost-effect
Publikováno v:
Health Care Management Science. 25:363-388
Depending on personal and hereditary factors, each woman has a different risk of developing breast cancer, one of the leading causes of death for women. For women with a high-risk of breast cancer, their risk can be reduced by two main therapeutic ap
Autor:
Yifan Lu, Ali Hajjar, Vincent L. Cryns, Amy Trentham‐Dietz, Ronald E. Gangnon, Brandy M. Heckman‐Stoddard, Oguzhan Alagoz
Publikováno v:
Cancer Medicine.
Diabetes mellitus has been associated with increased breast cancer (BC) risk; however, the magnitude of this effect is uncertain. This study focused on BC risk for women with type 2 diabetes mellitus (T2DM).Two separate meta-analyses were conducted (
Autor:
Ali Hajjar, Joe Tekli
Publikováno v:
New Trends in Database and Information Systems ISBN: 9783031157424
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39201b6abfdae512183bf7b7e1f35fd0
https://doi.org/10.1007/978-3-031-15743-1_23
https://doi.org/10.1007/978-3-031-15743-1_23
Autor:
Barry Martin, Harry J. de Koning, Sarocha Chootipongchaivat, Oguzhan Alagoz, Brian Chicoine, Mehmet Ali Ergun, Nicolien T. van Ravesteyn, Ali Hajjar, Jennifer M. Yeh
Publikováno v:
J Gen Intern Med
Journal of General Internal Medicine, 34(11), 2374-2381. Springer Nature
Journal of General Internal Medicine, 34(11), 2374-2381. Springer Nature
Women with Down syndrome have a lower breast cancer risk and significantly lower life expectancies than women without Down syndrome. Therefore, it is not clear whether mammography screening strategies used for women without Down syndrome would benefi
Autor:
Ali Hajjar, Oguzhan Alagoz
Publikováno v:
SSRN Electronic Journal.
Clinical practice guidelines do not sufficiently address the needs of patients with multiple chronic conditions (MCC) as these guidelines focus on single disease management and ignore unique patient-specific conditions. As a result, a non-personalize
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0217778 (2019)
PLoS ONE
PLoS ONE
ObjectivesAdjuvant paclitaxel and trastuzumab has been shown to be an effective regimen with low risk of cancer recurrence and treatment-related toxicities in early-stage node-negative, HER2-positive breast cancer. We investigated the cost-effectiven